We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Mystery of Behçet's Disease Revealed

By LabMedica International staff writers
Posted on 23 Jan 2013
Four new regions on the human genome that have been identified are associated with Behçet's disease, which causes inflammation of blood vessels in various parts of the body. More...


Behçet's disease is triggered by complex genetic and environmental factors and common symptoms include painful mouth and genital sores, and eye inflammation that can lead to blindness.

Scientists at the National Human Genome Research Institute (Bethesda, MD, USA) conducted a genome-wide association study (GWAS) that enrolled 1,209 Turkish people affected by Behçet's disease and 1,278 unaffected Turkish people, all of whom were indigenous residents of the country. The team looked at single-nucleotide polymorphisms (SNPs) on the human genome, with each SNP representing a difference in a single DNA building block and compared SNP differences between people with and without disease.

From nearly 800,000 SNPs, the investigators detected and mapped a small number that are found in those who have Behçet's disease at a significantly higher rate than in those without the disease, suggesting that the variant or another one nearby contributes to the disease. As not all the SNPs were genotyped, the team used the strategy of imputing, or surmising, that there were genotypes worth investigating near known variants.

An important association was found between Behçet's disease and a gene called endoplasmic reticulum aminopeptidase 1 (ERAP1) which codes for a molecule that processes microbial proteins in white blood cells. A significant association of Behçet's disease with variants near the chemokine (C-C motif) receptor 1 (CCR1) gene was also noted. Proteins coded by this gene help infection-fighting blood cells migrate to sites of invading microorganisms. An association of the disease was found with variants in the killer cell lectin-like receptor subfamily C, member 4 (KLRC4) gene and the signal transducer and activator of transcription 4 (STAT4) gene, in which different variants in the same vicinity of the genome increase risk for autoimmune diseases, including rheumatoid arthritis and lupus.

The four newly identified gene regions were already known to play a role in immune regulation. The genetic associations have helped classify Behçet's disease with more common inflammatory conditions such as psoriasis, inflammatory bowel disease, and a form of spinal arthritis called ankylosing spondylitis. Elaine F. Remmers, PhD, a coauthor of the study said, "Each of the genetic factors may contribute a little to the overall risk of disease. We are also identifying them in pathways that are important in inflammatory disease development." The study was published on January 6, 2013, in the journal Nature Genetics.

Related Links:

[US] National Human Genome Research Institute




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.